Technical factors of ERCP and the risk for postprocedural pancreatitis
Pancreatitis | p Value | ||||
---|---|---|---|---|---|
+ | − | ||||
Duration of ERCP (min) | 33 | 26 | 0.0273-150 | ||
Endoscopic papillotomy (EP) | |||||
Precut | 4 | 17 | 0.12 | ||
EP | 20 | 132 | 0.089 | ||
EP to pancreatic duct | 4 | 11 | 0.0423-150 | ||
Mean total volume of dye injected (ml) | |||||
Into CBD | 37 | 35 | 0.42 | ||
Into pancreatic duct | 4.5 | 6.5 | 0.97 | ||
Mean total number of injections | |||||
Into CBD | 4.0 | 4.5 | 0.27 | ||
Into pancreatic duct | 2.0 | 2.2 | 0.70 | ||
Contrast medium concentration | |||||
Omnipaque 140 mg/ml | 25 | 195 | 0.083 | ||
Omnipaque 240 mg/ml | 4 | 53. | 0.62 | ||
Extraction of calculi | 4 | 35 | 0.77 | ||
Stent placement and EP | 10 | 44 | 0.0123-150 | ||
Common bile duct dilatation | 1 | 5 | 0.45 | ||
Diagnostic procedure | 2 | 49 | 0.19 | ||
Total no. of patients | 31 | 277 |
↵3-150 Significance difference, tested with Fisher’s exact test or with the Mann-Whitney U test.